Gatifloxacin and Ethionamide as the Foundation for Therapy of Tuberculosis
The use of gatifloxacin (GAT) in combination with ethionamide (ETA) with or without pyrazinamide (PZA) for a 12-week treatment period followed by an 8-week observation period was evaluated in a model of tuberculosis in mice. Mice treated with GAT at 300 mg/kg of body weight in combination with ETA (...
-д хадгалсан:
| -д хэвлэсэн: | Antimicrob Agents Chemother |
|---|---|
| Үндсэн зохиолчид: | , |
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
American Society for Microbiology (ASM)
2003
|
| Нөхцлүүд: | |
| Онлайн хандалт: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166105/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12878502/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.8.2442-2444.2003 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|